BioCryst Pharmaceuticals
BCRX
#4789
Rank
$1.55 B
Marketcap
$7.49
Share price
0.40%
Change (1 day)
23.39%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $0.95 Billion USD

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are $0.95 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.97 B15.14%
2022-12-31$0.84 B21.5%
2021-12-31$0.69 B96.38%
2020-12-31$0.35 B158.32%
2019-12-31$0.13 B40.39%
2018-12-31$97.6 M3.3%
2017-12-31$94.49 M7.05%
2016-12-31$88.26 M18.27%
2015-12-31$74.63 M21.87%
2014-12-31$61.23 M22.5%
2013-12-31$49.99 M-13.65%
2012-12-31$57.89 M-14.11%
2011-12-31$67.4 M53.38%
2010-12-31$43.94 M-21.42%
2009-12-31$55.92 M46.15%
2008-12-31$38.26 M-50.82%
2007-12-31$77.81 M64.4%
2006-12-31$47.33 M15.98%
2005-12-31$40.8 M1201.96%
2004-12-31$3.13 M90.14%
2003-12-31$1.64 M40.65%
2002-12-31$1.17 M-48.66%
2001-12-31$2.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$0.81 B-15.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.37 B 147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.63 M-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.23 B 133.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$36.13 B 3,664.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$37.27 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$59.68 B 6,118.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.96 B 1.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$15.59 M-98.38%๐Ÿ‡บ๐Ÿ‡ธ USA